Position in PFE
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$4,051,195
-$451,096 QoQ
Shares Held
168,239
+4.9% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.36%
of 13F equity value
Holder Rank
#681
of 2,820 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FOSTER & MOTLEY INC holds $58,493,564 across 11 Drug Manufacturers - General names. PFE ranks #5 (6.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
57,981 | $14,590,338 | |
| 2 | AMGN |
Amgen Inc
|
32,896 | $11,912,299 | |
| 3 | JNJ |
Johnson & Johnson
|
45,340 | $11,514,999 | |
| 4 | MRK |
Merck & Co., Inc.
|
38,282 | $4,919,237 | |
| 5 | PFE |
Pfizer Inc
This page
|
168,239 | $4,051,195 | |
| 6 | NVS |
Novartis AG
|
21,447 | $3,361,173 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
56,454 | $3,252,879 | |
| 8 | GSK |
GSK plc
|
42,484 | $2,227,011 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,051,195 | 168,239 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $4,502,291 | 160,338 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $3,853,349 | 154,753 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $3,569,314 | 140,083 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $3,440,068 | 141,917 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $3,057,803 | 120,671 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $3,261,412 | 122,933 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $4,205,010 | 145,301 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $4,422,183 | 158,048 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $4,647,542 | 167,479 | Shares | Sole | 2024-04-18 | |
| 2023-12-31 | $5,399,679 | 187,554 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $6,546,132 | 197,351 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $7,667,367 | 209,034 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $9,132,264 | 223,830 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $11,870,309 | 231,661 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $10,287,319 | 235,085 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $12,243,191 | 233,515 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $12,201,878 | 235,694 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $14,132,259 | 239,327 | Shares | Sole | 2022-01-25 | |
| 2021-09-30 | $10,691,984 | 248,593 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $9,768,814 | 249,459 | Shares | Sole | 2021-07-20 | |
| 2021-03-31 | $8,981,453 | 247,901 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $9,132,376 | 248,095 | Shares | Sole | 2021-02-01 | |
| 2020-09-30 | $8,690,441 | 236,797 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $8,024,784 | 245,406 | Shares | Sole | 2020-07-20 | |
| 2020-03-31 | $7,970,448 | 244,193 | Shares | Sole | 2020-04-21 | |
| No filing history on record for this holder in this stock. | ||||||